Avacopan in ANCA ‐associated vasculitis: real‐world safety after postmarketing liver injury signals

Authors

Iftach Sagy (ORCID: https://orcid.org/0000-0002-2720-9934)
Rachel B Jones
Lucy Francis
Rona M Smith

Institutions

University of Cambridge (GB)
Cambridge University Hospitals NHS Foundation Trust (GB)

Publication Details

Journal: Arthritis & Rheumatology
Published: 2026-09-25
DOI: https://doi.org/10.1002/art.70329
Primary Topic: Vasculitis and related conditions
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

article

Avacopan in ANCA ‐associated vasculitis: real‐world safety after postmarketing liver injury signals

Iftach Sagy, Rachel B Jones, Lucy Francis, Rona M Smith

Sep 25, 2026

Arthritis & Rheumatology

Vasculitis and related conditions

article

Avacopan in ANCA ‐associated vasculitis: real‐world safety after postmarketing liver injury signals

Iftach Sagy, Rachel B Jones, Lucy Francis, Rona M Smith

September 25, 2026article en

Abstract

No abstract available for this paper.

Arthritis & Rheumatology

University of Cambridge (GB), Cambridge University Hospitals NHS Foundation Trust (GB)

Openalex Percentile: Top 12%

Vasculitis and related conditions

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Avacopan in ANCA ‐associated vasculitis: real‐world safety after postmarketing liver injury signals — Iftach Sagy, Rachel B Jones, et al. · Arthritis & Rheumatology (2026) | TGRS Research Map | TGRS